Abstract 3-(4-Aminophenyl)-1,2-dihydro-quinoxaline-2-one (2b), 3-(2-aminophenyl)-6,7-dimethyl-1,2-dihydro-quinoxaline-2-one (1b), its 3-(4-aminophenyl)-isomer (3b), 3-(2-aminobenzyl)-1,2-dihydro-quinoxaline-2-one (4b), its 3-(4-aminobenzyl)-isomer (6b), 3-(2-aminobenzyl)-6,7-dimethyl-1,2-dihydro-quinoxaline-2-one (5b) and its 3-(4-aminobenzyl)-isomer (7b) were diazotised and the resulting diazonium salts were coupled with ethyl cyanoacetylcarbamate, 3-methyl-1,2-dihydro-quinoxaline-2-one, 3,6,7-trimethyl-1,2-dihydro-quinoxaline-2-one and 3-methyl-6,7-dichloro-1,2-dihydro-quinoxaline-2-one. In this manner the corresponding hydrazones with one 1,2-dihydro-quinoxaline-2-one ring (1d, 3d, 5d, 7d) and hydrazones with two 1,2-dihydro-quinoxaline-2-one rings (3e-3g, 4e-4g, 5e-5g, 6e-6g, 7e-7g) were obtained. Cyclization of hydrazones (1d, 3d, 5d, 7d) afforded compounds (1h, 3h, 5h, 7h) containing 6-azauracil and also 1,2-dihydroquinoxaline-2-one rings. The starting amino derivative (1b) was prepared by the reaction of N-acetylisatine with 4,5-dimethyl-o-phenylenediamine followed by hydrolysis of the N-acetyl derivative. The amino derivative (5b) was prepared by the condensation of 2-nitrophenylpyruvic acid with 4,5-dimethyl-o-phenylenediamine and by reduction of the formed nitro derivative (5a). The amino derivative (3b) was prepared by the condensation of 4-acetylaminophenylglyoxylic acid with 4,5-dimethyl-o-phenylenediamine and hydrolysis of the N-acetyl derivative. The amino derivative (7b) resulted from the condensation of 4,5-dimethyl-o-phenylenediamine with 4-aminophenylpyruvic acid.
Introduction
Neurological diseases such as Creutsfeldt-Jacob disease, bovine spongiform encephalopathy and scrapie are caused by induced conformational changes of a normal host protein designated as PrP c to an abnormally folded protein designated as PrP Sc . Compounds which can affect the conformation of the protein chain could be helpful in treatment of such diseases. The newly discovered anti-prion compounds can be grouped into branched polyamines or rigid condensed heterocycles with tetrapyrrole or acridine skeletons 2 . 6,7-Dimethyl-1,2-dihydro-quinoxaline-2-ones substituted with 2-aminophenyl-, 4-aminophenyl-, 2-aminobenzyl-, and 4-aminobenzyl-groups in the 3-position were key intermediates in the synthesis of the aforementioned compounds. 
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The amino derivatives (1b), (2b), (3b), (4b), (5b), (6b) and (7b) were diazotised and the resulting diazonium salts coupled with ethyl cyanoacetylcarbamate, 3-methyl-1,2-dihydroquinoxaline-2-one, 3,6,7-trimethyl-1,2-dihydro-quinoxaline-2-one and 3-methyl-6,7-dichloro-1,2-dihydro-quinoxaline-2-one in an aqueous solution of sodium acetate to provide hydrazones (1d-1g, 2e-2g, 3d-3g, 4e-4g, 5d-5g, 6e-6g, 7d-7g) in good yields. Cyclization of hydrazones (1d, 3d, 5d, 7d) in alkaline solution led to compounds (1h, 3h, 5h, 7h) with 6-azauracil and 1,2-dihydro-quinoxaline-2-one rings. Hydrazones (1e-1g, 2e-2g, 3e-3g, 4e-4g, 5e-5g, 6e-6g, 7e-7g ) provided compounds with two 1,2-dihydro-quinoxaline-2-one moieties.
Starting amino derivatives were prepared in good yields from simple and easily accessible compounds. Compound (1b) was prepared from N-acetylisatine and 4,5-dimethyl-ophenylenediamine according to a modified 6 procedure of Schunck and Marchlewski 7 . Compound (5b) was prepared by the condensation of 4,5-dimethyl-o-phenylenediamine with 2-nitrophenylpyruvic acid followed by reduction of o-nitrobenzyl derivative (5a). The amino derivative (3b) was prepared by the condensation of 4-acetylaminophenylglyoxylic acid with 4,5-dimethyl-o-phenylenediamine followed by hydrolysis of the N-acetyl derivative (3c). The amino derivative (7b) was obtained by the condensation of 4,5-dimethyl-o-phenylenediamine with 4-aminophenylpyruvic acid.
In the IR spectra of compounds (1d-1h, 3d-3h, 5d-5h, 7d-7h) the N-H valence vibrations were observed between 3440-3325 cm -1 , resp. 3260-3240 cm -1 . The nitrile group in compounds (1d-1h, 3d-3h, 5d-5h, 7d-7h) vibrated near 2200 cm -1 . In the 1 H NMR spectra of compounds (1d-1h, 3d-3h, 5d-5h, 7d-7h) the chemical shifts of the methyl groups were between 2.30-2.34 ppm, the aromatic hydrogen atoms between 7.31-8.23 ppm and NH at 10.63-13.26 ppm.
Experimental Section
3-(4-Aminophenyl)-6,7-dimethyl-1,2-dihydroquinoxaline-2-one (3b). A mixture of acetyl derivative (3c) (3.89 g; 12.66 mmole) and a solution of KOH (6.5 g) in a mixture of ethanol (30 ml) and water (25 ml) was heated until a solution formed. The solution was then refluxed for 5 hours. The ethanol was evaporated from the reaction mixture by heating on a water bath and the solution was acidified with acetic acid to pH 5. The next day, a yellow crystalline compound was collected with suction, washed with water and dried in air. For further details see tables 1-3 in the supplementary material section. 3-(4-Acetylaminophenyl)-6,7-dimethyl-1,2-dihydroquinoxaline-2-one (3c). To a solution of 4,5-dimethyl-o-phenylenediamine (272,4 mg; 2,0 mmole) in hot ethanol (5 ml), was added a solution of p-acetylaminophenylglyoxylic acid 8 (414,38 mg; 2,0 mmole) in hot ethanol (8 ml). The reaction mixture was refluxed for 5 minutes. The next day upon cooling, a crystalline compound was collected with suction, washed with water and dried in air. For further details see tables 1-3 in the supplementary material section. 3-(2-Nitrobenzyl)-6,7-dimethyl-1,2-dihydroquinoxaline-2-one (5a). To the solution of onitrophenylpyruvic acid 9 (417.6 mg; 1.99 mmole) in ethanol (10 ml) was added a solution of 4,5-dimethyl-o-phenylenediamine (305.09 mg; 2.24 mmole) in hot ethanol (4 ml). The reaction mixture was refluxed for 5 minutes. The ethanol was evaporated and water (20 ml) was added to the reaction mixture. The next day, a crystalline compound was collected with suction, washed with water and dried in air. For further details see tables 1-3 in the supplementary material section. 3-(2-Aminobenzyl)-6,7-dimethyl-1,2-dihydroquinoxaline-2-one (5b). To solution of FeSO 4 . 7H 2 O (1.39 g; 5.0 mmole) in water (7 ml) was added to a solution of Ba(OH) 2 .8H 2 O in hot water (15 ml). The mixture of Fe(OH) 2 and BaSO 4 was quickly collected with suction and washed with hot ethanol. The mixture was added to a solution of 3-(2-nitrobenzyl)-6,7-dimethyl-1,2-dihydroquinoxaline-2-one (5a) (154,66 mg; 5,0 mmol) in hot ethanol (60 ml). The reaction mixture was refluxed for 90 minutes on a water bath and then filtered with suction and washed with hot ethanol. The filtrate was evaporated and the solution was mixed with a little water. The product was collected with suction, washed with water and dried in air. For further details see tables 1-3 in the supplementary material section. 3-(4-Aminobenzyl)-6,7-dimethyl-1,2-dihydroquinoxaline-2-one (7b). A solution of paminophenylpyruvic acid hydrochloride 10 (413.36 mg; 2.0 mmol) in ethanol (40 ml) was added to a solution of 4,5-dimethyl-o-phenylenediamine (272.4 mg; 2.0 mmol) in hot ethanol (8 ml). The reaction mixture was refluxed for 5 minutes and then evaporated to dryness. The resultant solid was dissolved in water (60 ml), and the pH was adjusted to 7 using ammonia solution. The next day, a crystalline compound was collected with suction, washed with water and dried. For further details see tables 1-3 in the supplementary material section.
General procedure of the synthesis of 1,2-dihydro-quinoxaline-2-ones substituted in position 3 (1d-7d, 1e-7e, 1f-7f, 1g-7g) A solution of NaNO 2 (140.0; 2.0 mmole) in ice-cold water (4 ml) was added portionwise under stirring to a solution (2.02 mmole) of the corresponding aromatic amine 2b-8b in a mixture of hydrochloric acid (37 %, 3.0 ml) and water (10-30 ml), which was cooled in an ice-bath. The solution was left to stand for 30-60 min and then was added portionwise during 10 min to a stirred mixture obtained by dissolving the following compounds as stated below.
For preparation of compounds (1d-7d): ethyl cyanoacetylcarbamate (0.42 g; 2.691 mmole) in warm water (110 ml), cooling on an ice bath, adding CH 3 COONa (5 g) and crushed ice.
For preparation of compounds (1e-7e): 3-methyl-1,2-dihydro-quinoxaline-2-one (324mg; 2.02 mmole) in water (2 ml) and acetic acid (15 ml), adding CH 3 COONa (1.0 g) and crushed ice.
For preparation of compounds (1f-7f): 3,6,7-trimethyl-1,2-dihydro-quinoxaline-2-one (380.2mg; 2.02 mmole) in water (2 ml) and acetic acid (30 ml), adding CH 3 COONa (2.0 g) and crushed ice.
In each case, the next day, a crystalline compound was collected with suction, washed with water and dried in air.
For compounds (1g-7g): 3-methyl-6,7-dichloro-1,2-dihydro-quinoxaline-2-one (462.0 mg; 2.02 mmole) in pyridine (30 ml) was used.
The next day, the reaction mixture was diluted with water and the next day, crystalline compound was collected with suction, washed with water and dried in air.
The data for these compounds are outlined in tables 1-3 in the supplementary material section.
2-[2-(2-Oxo-1,2-dihydro-6,7-dimethyl-quinoxalin-3-yl)-phenyl]-3,5-dioxo-2,3,4,5-tetra-hydro-1,2,4-triazin-6-carbonitrile (1h).
A mixture of hydrazone (1d) (0.432 g; 1.0 mmole), Na 2 CO 3 (120.0 mg) and water (10 ml) was heated on a boiling water bath until a solution was formed and then for an additional 15 minutes. The solution was then allowed to cool and acidified with hydrochloric acid (37 %) to pH 1. After several hours, the crystalline solid was collected by suction, washed with a little water and dried in air. Compounds (3h), (5h) and (7h) were prepared by analogy to (1h) from hydrazones (3d), (5d) and (7d). For further details see tables 1-3 in the supplementary material section. Melting points (Boetius) were not corrected. Infrared spectra were measured as potassium bromide disks and scanned on an ATI Unicam Genesis FTIR instrument. The NMR spectra were measured in DMSO-d 6 solutions on a Bruker AMX-360 spectrometer (360 MHz) with TMS as an internal standard. Elemental analyses were performed using an EA 1108 Elemental Analyzer (Fison Instrument).
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